NCT02619435 2023-03-24
STREAM
National Cancer Institute, Naples
Phase 2 Unknown
Clinical Trials
6 trialsNCT04764006 2021-11-04
Surufatinib Combined With Sintilimab for Advanced MSS-Type Colorectal Cancer : a Phase II Study
Fujian Cancer Hospital
Phase 2 Unknown
NCT03126071 2021-08-30
Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT04324476 2021-08-30
A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT04734249 2021-02-02
Second-line Surufatinib Combined With Chemotherapy in Advanced CRC
Fujian Cancer Hospital
Phase 2 Unknown
NCT00972465 2009-09-07
Study of Nimotuzumab to Treat Colorectal Cancer
Peking University
Phase 2 Unknown